Ampio Pharmaceuticals, Inc.
						AMPE
					
					
							
								$0.01
								-$0.14-96.39%
								
							
						OTC PK
					
				Rating
							Reward
									
							Risk
									
							Rating Factors
							Growth Index
									
							Efficiency Index
									
							Solvency Index
									
							Total Return Index
									
							Volatility Index
									
							Dividend Index
									
							Headlines
						There are no news to display.
							Income Statement
						Total Revenue (TTM)
							--
						EBITDA (TTM)
							
						EBIT (TTM)
							
						Net Income (TTM)
							
						Balance Sheet
						Total Assets (Q)
							
						Total Debt (Q)
							
						Total Liabilities (Q)
							
						Book Value Per Share (Q)
							
						Cash Flow
						Cash from Operations (TTM)
							
						Cash from Investing (TTM)
							--
						Cash from Financing (TTM)
							
						Net Change in Cash (TTM)
							
						Filings
						Filing Date
							Wednesday, March 27, 2024
						Period Date
							Sunday, December 31, 2023
						Next Filing
							 (est)
						Price History
						Beta
							
						7-Day Total Return
							
						30-Day Total Return
							
						60-Day Total Return
							
						90-Day Total Return
							
						Year to Date Total Return
							
						1-Year Total Return
							
						2-Year Total Return
							
						3-Year Total Return
							
						5-Year Total Return
							
						52-week Low
							
						52-week High
							
						Dividends and Shares
						Shares Outstanding
							
						Dividend Per Share (Most Recent)
							--
						Dividend Per Share (TTM)
							--
						Corporate Info
						Website
							
						Phone Number
							720 437 6500
						Address
							
9800 Mount Pyramid Court 
Englewood, CO 80112
						Englewood, CO 80112
Country
							
						Year Founded
							--
						Business Description
						Sector
							
						
								
									Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops...
									more